Published in Clin Infect Dis on October 01, 1994
Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. Springerplus (2015) 1.10
Three cases of bacteremia caused by Vibrio cholerae O1 in Blantyre, Malawi. Emerg Infect Dis (2001) 0.75
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol (1993) 4.36
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood (2000) 4.22
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol (1987) 3.17
Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun (1984) 3.14
Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol (1985) 2.97
Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother (1999) 2.80
Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis (1988) 2.71
Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med (1979) 2.61
Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis (1993) 2.42
Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun (1989) 2.30
Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol Lett (1994) 2.24
Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy. J Postgrad Med (2013) 2.05
Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J Antimicrob Chemother (1992) 2.04
Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis (1994) 1.87
Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J Clin Microbiol (1988) 1.87
Halobacterial flagellins are sulfated glycoproteins. J Biol Chem (1985) 1.85
A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study. Int J Clin Pract (2008) 1.74
Peer support for patients with type 2 diabetes: cluster randomised controlled trial. BMJ (2011) 1.69
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun (2000) 1.68
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia (2004) 1.62
Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol (1989) 1.61
Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J Immunol (1991) 1.60
Frozen biopsy specimens and culture rates of Helicobacter pylori. Lancet (1991) 1.57
Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (Biovar VA-I). J Infect (1983) 1.55
Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis (2000) 1.55
One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol (2003) 1.54
Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS (1999) 1.51
Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol (1988) 1.50
Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors. FEMS Microbiol Lett (1994) 1.50
Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS (1992) 1.47
Structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res (1990) 1.44
Occurrence of pathogenic vibrios in coastal areas of France. J Appl Microbiol (2002) 1.43
Chronic inflammatory demyelinating polyradiculoneuropathy associated with Evans' syndrome. Eur J Med (1992) 1.43
The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis (1994) 1.43
Sepsis-associated purpura fulminans in adults. Wien Klin Wochenschr (2001) 1.43
Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times. Thromb Haemost (1995) 1.42
Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec (2006) 1.42
Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs. J Clin Microbiol (2003) 1.42
[Plasmid resistance to 3d generation cephalosporins]. Presse Med (1988) 1.41
Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases. Antimicrob Agents Chemother (1997) 1.39
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther (2007) 1.39
Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo. J Infect Dis (1997) 1.38
[Reactivation of hepatitis B in AIDS]. Presse Med (1995) 1.37
Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. Appl Environ Microbiol (1991) 1.36
Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun (1981) 1.33
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol (1993) 1.33
Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1990) 1.29
Pathogenesis of diarrhoea caused by astrovirus infections in lambs. Arch Virol (1979) 1.28
Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic medium. J Gen Microbiol (1991) 1.28
Identification of an ancestral resistance gene cluster involved in the coevolution process between Phaseolus vulgaris and its fungal pathogen Colletotrichum lindemuthianum. Mol Plant Microbe Interact (1999) 1.27
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J Biol Chem (1998) 1.25
Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis (1992) 1.23
Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses (1999) 1.22
Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett (1999) 1.22
Optical matter: crystallization and binding in intense optical fields. Science (1990) 1.22
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol (2001) 1.21
Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci U S A (2000) 1.21
Individualisation of two new genomic groups among American Borrelia burgdorferi sensu lato strains. FEMS Microbiol Lett (1994) 1.20
Two variants of transferrable extended-spectrum TEM-beta-lactamase successively isolated from a clinical Escherichia coli isolate. FEMS Microbiol Lett (1992) 1.18
Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J Virol (1998) 1.18
Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17
Cholera in Madagascar. Lancet (1999) 1.16
Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2). J Bacteriol (2001) 1.12
Asparaginyl-N-acetylgalactosamine. Linkage unit of halobacterial glycosaminoglycan. J Biol Chem (1986) 1.11
Injury Severity Score (ISS) as a yardstick in assessing the severity and mortality of various abdomino-pelvic trauma hospitalized victims--a clinical vis-à-vis autopsy study. Med Sci Law (1989) 1.10
Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med (1994) 1.09
Nucleotide sequence of the bla(RTG-2) (CARB-5) gene and phylogeny of a new group of carbenicillinases. Antimicrob Agents Chemother (2000) 1.08
Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone. Exp Clin Endocrinol Diabetes (2007) 1.07
Emergence of cholera in the Central African Republic. Eur J Clin Microbiol Infect Dis (1998) 1.07
Haemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review. J Infect (1997) 1.06
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida. AIDS Res Hum Retroviruses (1999) 1.05
HIV infection as a risk factor for septic arthritis. Br J Rheumatol (1997) 1.05
Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8. J Infect Dis (1991) 1.05
Nontoxigenic vibrio Cholerae O1 bacteremia: case report and review. Eur J Clin Microbiol Infect Dis (2000) 1.04
Capnocytophaga canimorsus in the oral flora of dogs and cats. J Infect (1998) 1.03
Characterization and nucleotide sequence of CARB-6, a new carbenicillin-hydrolyzing beta-lactamase from Vibrio cholerae. Antimicrob Agents Chemother (1999) 1.03
[Retrospective evaluation of the detection of Toxoplasma gondii by polymerase chain reaction in AIDS patients]. Presse Med (1996) 1.03
Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8. J Clin Microbiol (1990) 1.02
Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr (1998) 1.01
Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations. Infect Immun (1981) 1.01
Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus. Infect Immun (1996) 1.00
IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses (2000) 0.99
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins]. Presse Med (1985) 0.98
Optimization of network robustness to waves of targeted and random attacks. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.97
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. Proc Natl Acad Sci U S A (1998) 0.97
Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun (2001) 0.97
[Bacterial flora in gastric juice taken at endoscopy in 93 normal subjects]. Pathol Biol (Paris) (1986) 0.96
Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm (2008) 0.96
Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1. Microbiology (1999) 0.96